Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

Matched clinical trials

  • Study comparing ALG-000184 with tenofovir disoproxil in untreated adults with chronic hepatitis B virus infection

    Recruiting

    1 1
    Investigated diseases:
    Bulgaria France Italy Romania Spain
  • A study to evaluate the safety and effectiveness of MRNA3771 and GRNA1599 in adults with chronic hepatitis B

    Recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    France
  • Study on the Safety and Efficacy of a Hepatitis B Vaccine with Hepatitis B Surface Antigen (rDNA), MVA-HBVAC, and Mosaic HBcoreAg for Adults with Chronic Hepatitis B

    Recruiting

    1 1
    Investigated diseases:
    Germany
  • Study of Tenofovir Alafenamide for Children and Teens with Chronic Hepatitis B

    Not yet recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Romania
  • Study of Bepirovirsen for Patients with Chronic Hepatitis B on Nucleos(t)ide Analogue Treatment

    Not recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Bulgaria France Germany Greece Hungary Italy +3
  • Study of GSK3965193 and Bepirovirsen for People Living with Chronic Hepatitis B Infection and Healthy Participants

    Not recruiting

    Investigated diseases:
    Investigated drugs:
    France Italy
  • Study on Stopping Tenofovir Alafenamide, Tenofovir Disoproxil, and Entecavir in Patients with Chronic Hepatitis B

    Not recruiting

    1 1 1
    Investigated diseases:
    Belgium
  • Study on the Safety and Effectiveness of Terbinafine for Patients with Chronic Hepatitis B

    Not recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands
  • Study on the Safety and Effectiveness of VIR-2218, VIR-3434, and Peginterferon Alfa-2a for Patients with Chronic Hepatitis B

    Not recruiting

    1 1 1
    Investigated diseases:
    Germany Romania
  • Study of tenofovir disoproxil versus placebo for children aged 2-12 years with chronic hepatitis B infection

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Romania